J. G. Harter

发表

Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration.

K. Ishak, H. Zimmerman, E. Tarazi, 1993, Gastroenterology.

Diclofenac‐associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions

K. Ishak, H. Zimmerman, J. G. Harter, 1995, Hepatology.

Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

W. H. Barr, L. Benet, D. Furst, 1993, Springer US.

THE STATUS OF DIMETHYL SULFOXIDE FROM THE PERSPECTIVE OF THE FOOD AND DRUG ADMINISTRATION

J. G. Harter, J. Harter, 1983, Annals of the New York Academy of Sciences.

PURIFICATION AND ANALYSIS OF FLUORESCEIN-LABELED ANTISERA BY COLUMN CHROMATOGRAPHY.

H. Mcdevitt, A. H. Coons, J. G. Harter, 1963, Journal of immunology.

THE LOCALIZATION OF ALBUMIN AND FIBRINOGEN IN HUMAN LIVER CELLS

Y. Hamashima, A. H. Coons, J. G. Harter, 1964, The Journal of cell biology.

Refinements of acrylamide electrophoresis.

R. Ritchie, J. G. Harter, T. B. Bayles, 1966, The Journal of laboratory and clinical medicine.

Digoxin—The Regulatory Viewpoint

J. Skelly, J. G. Harter, A. W. Steers, 1974 .

STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN.

G. W. Thorn, W. Reddy, J. G. Harter, 1963, The New England journal of medicine.

Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

Lewis B. Sheiner, Vinod P. Shah, C. T. Viswanathan, 1992, Pharmaceutical Research.

Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

C. T. Viswanathan, Avraham Yacobi, Gerhard Levy, 1992, Clinical pharmacology and therapeutics.

Acute Flank Pain and Hematuria: Lessons from Adverse Drug Reaction Reporting

J. G. Harter, 1988, Journal of clinical pharmacology.

Studies on ragweed pollen. I. Preliminary fractionation of ragweed pollen; characterization and allergenicity of the isolated fractions.

A. Sehon, B. Rose, J. G. Harter, 1956, The Journal of allergy.

Localization of blocking antibody in sera of ragweed-sensitive individuals by starch electrophoresis.

A. Sehon, B. Rose, J. G. Harter, 1957, The Journal of allergy.

THE LOCALIZATION OF SKIN-SENSITIZING ANTIBODY IN THE SERA OF RAGWEED-SENSITIVE INDIVIDUALS BY ELECTROPHORESIS

A. Sehon, B. Rose, J. G. Harter, 1956, The Journal of experimental medicine.

Studies on ragweed pollen. III. Estimation of the minimum number of allergens in the water soluble extract of ragweed pollen and a critical evaluation of the neutralization technique; the demonstration of two different reagins in sera of ragweed sensitive individuals.

A. Sehon, B. Rose, J. G. Harter, 1957, Journal of immunology.

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

G Levy, C. T. Viswanathan, C C Peck, 1992, Journal of clinical pharmacology.

An evaluation of Gay's solution in the treatment of asthma.

J. G. Harter, J. Harter, A. Novitch, 1967, The Journal of allergy.

Chronobiology. Suggestions for integrating it into drug development.

C. Peck, J. G. Harter, J. Harter, 1991, Annals of the New York Academy of Sciences.

Diclofenac‐associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions

K. Ishak, H. Zimmerman, J. G. Harter, 1995, Hepatology.

Serum uric acid levels in patients with bronchial asthma.

J. G. Harter, 1968, Journal of Allergy.

Comments from the Food and Drug Administration

J. G. Harter, 1975 .

Successful initiation of alternate-day prednisone in chronic steroid-dependent asthmatic patients.

J. G. Harter, J. Kent, S. Rayyis, 1972, The Journal of allergy and clinical immunology.